Display Settings:

Format

Send to:

Choose Destination
    Br J Rheumatol. 1990 Jun;29(3):211-3.

    Failure of selenium-ace to improve osteoarthritis.

    Source

    Clinical Pharmacology Unit (Rheumatism Research), Royal Bath Hospital, Harrogate, UK.

    Abstract

    Selenium-ACE, a formulation containing the trace element selenium with three vitamins, is widely promoted for the treatment of arthritis. A controlled double-blind trial of Selenium-ACE in osteoarthritis failed to demonstrate any significant efficacy for the compound over placebo at 3 or 6 months though there was a non-significant trend to improvement in some clinical parameters in both groups. Side-effects were more frequently seen in the placebo group.

    PMID:
    2192771
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Icon for HighWire Press

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk